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Abstract
Renal angiomyolipomas (AML) are benign lesions usually left alone. However, lesions larger than 4 cm carry the 
risk of spontaneous haemorrhage and need treatment. Angiography and embolisation are the current standard of 
care particularly in patients with high operative risks. Angio-embolisation is a safe, minimally invasive procedure 
preserving maximum renal parenchyma, with the added advantage of preventing peri-procedural morbidity. Two cases 
of AML are presented in this case series.
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Introduction
Renal angiomyolipomas (AML) are benign lesions usually 
left alone. However, lesions larger than 4 cm carry the 
risk of spontaneous haemorrhage and need treatment. 
Angiography and embolisation are the current standard of 
care particularly in patients with high operative risks.[1-3] 
We share two cases of AML presenting with peri-tumoral 
haemorrhage treated with angiography and embolisation.
Case Report
Case 1
A 59-year-old lady with multiple comorbidities (Diabetes, 
hypertension, prior history of cardiac valve surgery, 
CABG and pacemaker in situ) presented with left 
flank pain. Computed tomography showed a large left 
renal lower pole AML measuring 7 cm with a perirenal 
haematoma. After obtaining medical and cardiac fitness, 
antiplatelet and anticoagulant therapy was held to obtain 
normal coagulation status. Angiography demonstrated an 
ectatic aneurysmal segmental left renal artery supplying 
AML. Embolisation was performed using two vials of 
PVA particles (500–700 μ) through a 4 Fr C2 catheter.
Post-procedure angiogram demonstrated preserved 
left renal parenchyma without any flow into the AML. 
[Figure 1a-e] Patient had an uneventful recovery and 
anticoagulant therapy was reinstated the following day 
after the procedure [Figures 1 and 2a-e].
Case 2
A 44-year-old lady with no comorbid presented with 
severe left flank pain followed by hypotension. She was 
Figure 1:  Unenhanced computed tomography (CT) 
(a) demonstrating fat containing lesion at the lower pole of the 
left kidney with surrounding high-density haemorrhage. Note 
the thickening of lateroconal fascia. Axial post-contrast CT 
(b) remonstrates the angiomyolipomas (AML) with haemorrhage 
and internal high-density aneurysmal vessels. Left renal branch 
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resuscitated at an outside facility and workup showed 
a large right upper renal pole AML measuring 9 cm 
with large perirenal haematoma, small intraperitoneal 
haemorrhage and right pleural effusion. The AML was 
predominantly being supplied by a small branch arising 
directly from aorta adjacent to the superior mesenteric 
artery leading to multiple large aneurysmal dilatations 
within the AML [Figure 3a-e].
It was engaged with 5 Fr SIM-2 catheter and 2.7 Fr 
microcatheter was then used to embolise the AML using a 
combination of three vials of PVA particles and five coils 
of various sizes. Post-procedure angiogram demonstrated 
Figure 2: Post-embolisation selective angiogram of the upper 
branch of the left renal artery (a and b) and left renal angiogram 
(c) demonstrated complete devascularisation of the left lower 
pole. Follow-up computed tomography done after 6 weeks 





Figure 3: Unenhanced (a), MIP arterial phase (b) and venous 
phase computed tomography (c) demonstrate large right upper 
pole fat containing lesion with predominant supply from an 
accessory branch directly arising from aorta adjacent to the origin 
of SMA. Large intralesional aneurysms are also seen. Angiogram 
performed through SIM-2 catheter in the accessory branch 
from aorta (d) outlines the accessory vessel and intralesional 
aneurysms. Progreat microcatheter in the branch was used to 




Figure 4: Post PVA angiogram (a) demonstrates persistent flow 
in the aneurysmal vessels. Multiple coils (b) were used to achieve 
complete stasis (c). Selective right renal artery angiogram (d) 
demonstrates very tiny branches supplying the inferior aspect 
of the angiomyolipomas. These were too tiny to be selectively 
catheterised and embolisation of this branch would compromise 
right renal interpolar region. It was decided to preserve renal tissue. 
Follow-up computed tomography including unenhanced (e), 
arterial (f) and venous phase (g) demonstrate interval decrease 
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near complete occlusion of the feeding artery [Figure 4a-g]. 
The patient had an uneventful recovery.
Discussion
AMLs are benign mostly asymptomatic renal masses that 
are largely detected incidentally. Treatment is necessary 
for symptomatic patients or when the lesion size exceeds 
4 cm.[4] The aim is to relieve symptoms and prevent 
haemorrhage, with the priority of preserving renal function. 
Treatment options include arterial embolisation or surgical 
excision. Angio-embolilsation carries the advantage of 
being minimally invasive, preservation of renal function 
and rapid haemodynamic stabilisation in settings of acute 
intra/peri-lesional haemorrhage.[3,5] Optimal candidates for 
embolisation are tumours receiving blood supply by a single 
arterial branch. In tumours with complex vascular anatomy, 
embolisation of multiple branches is technically challenging 
with an increased risk of embolising adjoining normal renal 
parenchyma with potential functional compromise.[6,7,8]
Conclusion
Embolisation of renal AML is a safe minimally invasive 
procedure preserving maximum renal parenchyma, 
with the added advantage of preventing peri-procedural 
morbidity. We recommend it as first-line treatment for all 
AML’s requiring treatment. 
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